Literature DB >> 15755738

Analysis of ARD1 function in hypoxia response using retroviral RNA interference.

Tim S Fisher1, Shelley Des Etages, Lisa Hayes, Kim Crimin, Baiyong Li.   

Abstract

Cellular hypoxia response is regulated at the level of hypoxia-inducible factor (HIF) activity. A number of recently identified oxygen sensors are HIF-modifying enzymes that respond to low oxygen by altering HIF modification and thus lead to its activation. In addition to the HIF proline hydroxylases and asparagine hydroxylases, ARD1 is recently described as a HIF-1alpha acetylase that regulates its stability. We found that ARD1 is down-regulated in a number of cell lines in response to hypoxia and hypoxia mimic compounds. After surveying these lines for erythropoietin production and retroviral transfection efficiency, we chose to use HepG2 cells to study the function of ARD1. ARD1 short hairpin RNA delivered by a retroviral vector caused >80% reduction in ARD1 message. We observed decreases in erythropoietin and vascular endothelial growth factor protein production, whereas there was no change in the HIF-1alpha protein level. A gene chip analysis of HepG2 cells transduced with virus expressing ARD1 short hairpin RNA under normoxia and hypoxia conditions or with virus overexpressing recombinant ARD1 confirmed that inhibition of ARD1 does not cause activation of HIF and downstream target genes. However, this analysis revealed that ARD1 is involved in cell proliferation and in regulating a series of cellular metabolic pathways that are regulated during hypoxia response. The role of ARD1 in cell proliferation is confirmed using fluorescence labeling analysis of cell division. From these studies we conclude that ARD1 is not required to suppress HIF but is required to maintain cell proliferation in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755738     DOI: 10.1074/jbc.M412055200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Human protein N-terminal acetyltransferase hNaa50p (hNAT5/hSAN) follows ordered sequential catalytic mechanism: combined kinetic and NMR study.

Authors:  Rune H Evjenth; Annette K Brenner; Paul R Thompson; Thomas Arnesen; Nils Åge Frøystein; Johan R Lillehaug
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

2.  A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.

Authors:  Petra Van Damme; Svein I Støve; Nina Glomnes; Kris Gevaert; Thomas Arnesen
Journal:  Mol Cell Proteomics       Date:  2014-01-09       Impact factor: 5.911

Review 3.  The emerging role of acetylation in the regulation of autophagy.

Authors:  Agnes Bánréti; Miklós Sass; Yacine Graba
Journal:  Autophagy       Date:  2013-03-06       Impact factor: 16.016

4.  HEXIM1 down-regulates hypoxia-inducible factor-1α protein stability.

Authors:  I-Ju Yeh; Ndiya Ogba; Heather Bensigner; Scott M Welford; Monica M Montano
Journal:  Biochem J       Date:  2013-12-01       Impact factor: 3.857

5.  hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing.

Authors:  Chung-Fan Lee; Derick S-C Ou; Sung-Bau Lee; Liang-Hao Chang; Ruo-Kai Lin; Ying-Shiuan Li; Anup K Upadhyay; Xiaodong Cheng; Yi-Ching Wang; Han-Shui Hsu; Michael Hsiao; Cheng-Wen Wu; Li-Jung Juan
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

6.  Expression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilum.

Authors:  Sang Hee Han; Jun Yong Ha; Kyoung Hoon Kim; Sung Jin Oh; Do Jin Kim; Ji Yong Kang; Hye Jin Yoon; Se-Hee Kim; Ji Hae Seo; Kyu-Won Kim; Se Won Suh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

7.  A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.

Authors:  Taraneh Esmailpour; Hamidreza Riazifar; Linan Liu; Sandra Donkervoort; Vincent H Huang; Shreshtha Madaan; Bassem M Shoucri; Anke Busch; Jie Wu; Alexander Towbin; Robert B Chadwick; Adolfo Sequeira; Marquis P Vawter; Guoli Sun; Jennifer J Johnston; Leslie G Biesecker; Riki Kawaguchi; Hui Sun; Virginia Kimonis; Taosheng Huang
Journal:  J Med Genet       Date:  2014-01-15       Impact factor: 6.318

8.  Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Authors:  Amagoia Ametzazurra; Cristina Gázquez; Marta Lasa; Esther Larrea; Jesús Prieto; Rafael Aldabe
Journal:  BMC Proc       Date:  2009-08-04

9.  Composition and biological significance of the human Nalpha-terminal acetyltransferases.

Authors:  Kristian K Starheim; Darina Gromyko; Rolf Velde; Jan Erik Varhaug; Thomas Arnesen
Journal:  BMC Proc       Date:  2009-08-04

Review 10.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.